|
Lipid nanoparticle delivery of CRISPR/Cas9 reagents for disruption of oncogenic translocations in alveolar rhabdomyosarcoma |
University of California, Los Angeles |
Northwestern Mutual Foundation |
|
Testing a novel acylfulvene in malignant rhabdoid tumor |
The Johns Hopkins University School of Medicine |
Northwestern Mutual Foundation |
|
Regulation of medulloblastoma metastasis by the FOS transcription factor |
Columbia University Medical Center |
Northwestern Mutual Foundation |
|
CAR-boosting vaccines for neuroblastoma |
Children’s Hospital of Philadelphia |
Northwestern Mutual Foundation |
|
Evaluating disease response using volumetric analysis vs 2D cross sectional analysis |
University of Michigan |
Northwestern Mutual Foundation |
|
Targeting cancer-specific non-protein molecular signatures for immunotherapy of pediatric AML
|
Hackensack Meridian Health Center for Discovery and Innovation |
The Mya Lin Terry Foundation |
|
The role of reactive gliosis in response to Immunotherapy in Diffuse Midline Glioma |
University of Florida |
Little Hero Foundation |
|
The role of reactive gliosis in response to Immunotherapy in Diffuse Midline Glioma |
University of Florida |
Little Hero Foundation |
|
Targeting and imaging immunometabolic vulnerabilities in diffuse midline glioma |
The Regents of the University of California San Francisco |
Storm The Heavens Fund |
|
Epigenetic control of cell state in retinoid resistant neuroblastoma |
Dana-Farber Cancer Institute |
Northwestern Mutual Foundation |
